Cue Biopharma reported raising $50 Million in an initial SEC Form D filing, from an offering of $50 Million
Round Type
Venture
BostonBiotechnologyHealth CareTherapeuticsQuick answer
Cue Biopharma raised $50 Million in a funding round, dated July 13, 2026. Cue Biopharma is based in Boston, Massachusetts, United States.
- How much did Cue Biopharma raise?
- Cue Biopharma raised $50 Million in a funding round on July 13, 2026.
- What does Cue Biopharma do?
- Cue Biopharma, a clinical-stage biopharmaceutical company is developing a novel class of therapeutic biologics to selectively engage and modulate disease-relevant T cells for the treatment of autoimmune disease.
- Where is Cue Biopharma based and how big is it?
- Cue Biopharma is based in Boston, Massachusetts, United States. Fundz records about 29 employees.
- Who are the decision-makers at Cue Biopharma?
- Fundz holds 2 contacts at Cue Biopharma, including the Biotech CEO | Board Member & Chairman| LifeScience Advisor. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Cue Biopharma that raised within 45 days of this round, from Fundz verified event records.
- Redx raised $36M (Series A) on August 27, 2026.
- BioLineRx Ltd raised $3.8M on August 27, 2026.
- Airway Therapeutics, LLC raised $50M (Series E) on August 25, 2026.
- Revier Therapeutics raised $7M (Seed) on August 25, 2026.
- Amylyx Pharmaceuticals raised $500M (Post-IPO Equity) on August 20, 2026.
- Kynexis raised $46M (Series A) on August 19, 2026.
Who to call at Cue Biopharma, and when
A new round usually means Cue Biopharma is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Cue Biopharma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Cue Biopharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Cue Biopharma. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Cue Biopharma raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Cue Biopharma raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.